{"name":"Nexcella Inc.","slug":"nexcella-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQV1JBcWNmYk85cFJyVU9PYzE1c0x3b2RjcW9fN1JUQ1FNc1BRUjNMRkltMTl3cHZCdnpoOHFvQlFCY3BrQ0ZWa1lxQnNCb055NlZyVlcwelZGd1hxRmhCVnBybXdSS1B3eFJZT1JUV0JfWGFEM2Vvc3ZJNzdRdUlPcmR4YkJjSEEyWGhIYm0xZkk0cXJLTzNXeXR3anY5cjA4eEQwbzNVWjUtSWxDdm55Ti0zWFh3TW8zUnlRcmpVTFhQc0NCMmJydTdVUzBYbXdGbGR5R2xPeWNLX3VuV0t6bWduNW1GYnhSYl8zbmFfa2lteDBGTzNtQUlKNHlOczZjYXFISHdpc3dtUm9IY0FCNmQwZ2hPeEhYdTAwaFFwTXlGd2Z4NHdpbUxiZXU1dGM5UjBrVjQ2UTc5QlJkM0NyUVlQWnBQTkU?oc=5","date":"2025-03-05","type":"trial","source":"GlobeNewswire","summary":"CAR T-cell Therapy Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"CAR T-cell Therapy Clinical Trial Pipeline Experiences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPcWZBMGl4cGNZWURPb3hqMVJlS2RDRmlKb1dkR1dpdDFWWE9GdTdFMDZYLVMwTGpUZ21qR2pCZ0lXTDRFQVBXaElGSkZ0NWJLOFRTZWxMd3BzMGd2ckF1TkJ2Z21ySUlvQmJJc3l6enZLa256dl9obUtQejdtZFoyU1ZtNVlVb2l0YW9EMHRubG5wS3piZDBHVEdn?oc=5","date":"2023-09-19","type":"pipeline","source":"Contract Pharma","summary":"Nexcella Completes 2nd NXC-201 Engineering Batch - Contract Pharma","headline":"Nexcella Completes 2nd NXC-201 Engineering Batch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPQ2dlVmJjN05jN2RnOTdrQ1JXdFkzcU13bG5iQzhCR3lHemNCNlpTSHRWbG1wcU9ndjI4Y2xrMDJhTW5fZlVBS2dJOExCNkcwYmxOMnRjRFY3TXdDZ0lmQzVlUV9POHRtNTFvZDJjT0Q4Y2NQRmlkOVp6TW05RktIWHh5STBNY05jNjdwUEZSV3daVkNnVlB0VjRiVU4?oc=5","date":"2023-05-26","type":"pipeline","source":"Contract Pharma","summary":"Nexcella Starts NXC-201 Engineering Batches at U.S. CAR-T Manufacturing Site - Contract Pharma","headline":"Nexcella Starts NXC-201 Engineering Batches at U.S. CAR-T Manufacturing Site","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}